PEA15 and non-small cell lung carcinoma: For example, the expression of PEA15 was found to be increased in non-small cell lung cancer [39], chronic lymphocytic leukemia [40], thyroid cancer [41], prostate cancer [42] and liver cancer cells [43], where it inhibited apoptosis and promoted tumor growth.